These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 21351243)

  • 21. Obesity and fatty liver are 'grease' for the machinery of hepatic fibrosis.
    Bosserhoff A; Hellerbrand C
    Dig Dis; 2011; 29(4):377-83. PubMed ID: 21894008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Relationship between carotid atherosclerosis and nonalcoholic fatty liver disease].
    Zhang Y; Xu SH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):875-6. PubMed ID: 19958653
    [No Abstract]   [Full Text] [Related]  

  • 23. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary biliary cirrhosis is more severe in overweight patients.
    Híndi M; Levy C; Couto CA; Bejarano P; Mendes F
    J Clin Gastroenterol; 2013 Mar; 47(3):e28-32. PubMed ID: 23059407
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.
    Munteanu M; Ratziu V; Morra R; Messous D; Imbert-Bismut F; Poynard T
    J Gastrointestin Liver Dis; 2008 Jun; 17(2):187-91. PubMed ID: 18568141
    [No Abstract]   [Full Text] [Related]  

  • 26. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
    Sung KC; Ryan MC; Wilson AM
    Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significant correlations between severe fatty liver and risk factors for metabolic syndrome.
    Hsiao PJ; Kuo KK; Shin SJ; Yang YH; Lin WY; Yang JF; Chiu CC; Chuang WL; Tsai TR; Yu ML
    J Gastroenterol Hepatol; 2007 Dec; 22(12):2118-23. PubMed ID: 18031368
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes of liver transplantation in patients with cirrhosis due to nonalcoholic steatohepatitis versus patients with cirrhosis due to alcoholic liver disease.
    Bhagat V; Mindikoglu AL; Nudo CG; Schiff ER; Tzakis A; Regev A
    Liver Transpl; 2009 Dec; 15(12):1814-20. PubMed ID: 19938128
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ethnic and sex differences in the association between metabolic syndrome and suspected nonalcoholic fatty liver disease in a nationally representative sample of US adolescents.
    Graham RC; Burke A; Stettler N
    J Pediatr Gastroenterol Nutr; 2009 Oct; 49(4):442-9. PubMed ID: 19644391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pathology of nonalcoholic fatty liver disease.
    Yeh MM; Brunt EM
    Am J Clin Pathol; 2007 Nov; 128(5):837-47. PubMed ID: 17951208
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nutrition and nonalcoholic fatty liver disease? Still in search of evidence!
    Braillon A
    Am J Gastroenterol; 2007 May; 102(5):1134. PubMed ID: 17489796
    [No Abstract]   [Full Text] [Related]  

  • 32. Ultrasound evaluation and correlates of fatty liver disease: a population study in a Mediterranean area.
    Chiloiro M; Caruso MG; Cisternino AM; Inguaggiato R; Reddavide R; Bonfiglio C; Guerra V; Notarnicola M; De Michele G; Correale M; Noviello MR; Misciagna G
    Metab Syndr Relat Disord; 2013 Oct; 11(5):349-58. PubMed ID: 23758075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Predictors of liver fibrosis in patients with non-alcoholic fatty liver disease. The role of metabolic syndrome, insulin-resistance and inflammation].
    Andreozzi P; Viscogliosi G; Colella F; Subic M; Cipriani E; Marigliano B; Verrusio W; Servello A; Ettorre E; Marigliano V
    Recenti Prog Med; 2012 Dec; 103(12):570-4. PubMed ID: 23258240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of non-alcoholic fatty liver disease on chronic hepatitis B.
    Bondini S; Kallman J; Wheeler A; Prakash S; Gramlich T; Jondle DM; Younossi ZM
    Liver Int; 2007 Jun; 27(5):607-11. PubMed ID: 17498244
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.
    Angulo P; Keach JC; Batts KP; Lindor KD
    Hepatology; 1999 Dec; 30(6):1356-62. PubMed ID: 10573511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Peculiarities of metabolic syndrome and nonalcogolic fatty liver disease in menopausal women].
    Antelava NA; Antelava AV; Gongadze MV; Okudzhava MV; Pachkoriia KZ; Gogolauri MI
    Georgian Med News; 2012 Jul; (208-209):16-23. PubMed ID: 22899406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity, hyperlipidemia, and metabolic syndrome.
    Charlton M
    Liver Transpl; 2009 Nov; 15 Suppl 2():S83-9. PubMed ID: 19877024
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Late recurrence and rapid evolution of severe hepatopulmonary syndrome after liver transplantation.
    Krowka MJ; Wiseman GA; Steers JL; Wiesner RH
    Liver Transpl Surg; 1999 Sep; 5(5):451-3. PubMed ID: 10477847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma plasminogen activator inhibitor-1 levels and nonalcoholic fatty liver in individuals with features of metabolic syndrome.
    de Larrañaga G; Wingeyer SP; Graffigna M; Belli S; Bendezú K; Alvarez S; Levalle O; Fainboim H
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):319-24. PubMed ID: 18160600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.